Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 4;18(1):118.
doi: 10.1007/s12105-024-01726-2.

Malignant Salivary Gland Neoplasm of the Tongue Base with EWSR1::BEND2 Fusion: An Unusual Case with Literature Review

Affiliations
Review

Malignant Salivary Gland Neoplasm of the Tongue Base with EWSR1::BEND2 Fusion: An Unusual Case with Literature Review

Yuan-Dong Zhang et al. Head Neck Pathol. .

Abstract

Purpose: Salivary gland malignancies may have overlapping architectural patterns, tumor morphology, and immunohistochemical phenotypes, presenting challenges in precise classification. Molecular phenotyping has become quite useful for providing an additional diagnostic modality, and potential drug targets. Here we reported a young female patient with salivary gland tumor of the tongue base harboring genetic alterations by next generation sequencing (NGS).

Methods: The morphological, immunohistochemical and molecular features of this case were described, and related literature was reviewed.

Results: The tumor showed an epithelial myoepithelial architecture arranged in cords and tubules interwoven with a chondromyxoid stroma, along with perineural invasion and adjacent striated muscle infiltration. Myoepithelial cells were positive for CK5/6, partially positive for P63 and CK7, and sporadically positive for S100. Immunoprofiling revealed a low density of infiltrating lymphocytes and macrophages and the absence of programmed death ligand 1 (PD-L1). Notably, RNA-based NGS showed EWSR1::BEND2 gene fusion in this tumor, and EWSR1 break-apart was confirmed by fluorescence in situ hybridization. This led to a final diagnosis of a minor salivary gland malignancy with EWSR1::BEND2 fusion. Only two other cases of salivary gland tumors with EWSR1::BEND2 fusion had been previously reported, which were also detected via RNA-based NGS.

Conclusion: This study emphasized that EWSR1::BEND2 fusion may drive the carcinogenesis in salivary glands neoplasia. In clinic RNA-based NGS could be essential for precise genotyping of EWSR1 fusion in this rare disease.

Keywords: BEND2; EWSR1; Minor salivary gland carcinoma; Next-generation sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Maxillofacial and neck magnetic resonance imaging AB. Transverse and coronal T2-weighted postgadolinium MR images revealed a heterogeneous linear sheet-enhancing mass with distinct peripheral ring enhancement at the right base of the tongue, measuring approximately 2.5 cm × 1.7 cm × 2.0 cm. C. Sagittal T1-weighted postgadolinium MR image demonstrating that the lesion was adjacent to the lower border of the right palatine tonsil and slightly compressed the oropharyngeal epiglottis
Fig. 2
Fig. 2
H&E staining of expectorate and needle puncture biopsy tissue. H&E staininh of the expectorate: A-B. The expectorate showed a polypoid growth pattern with mild atypia squamous epithelium and high cellularity stroma (40 × , 100 ×); C. The cells melted into the chondromyxoid stroma under the epithelium (200 ×). H&E staining of core needle puncture biopsy tissue: DE. The tumor cells exhibited an invasive growth pattern (40 × ,100 ×); F. Bilayer tubular, cord and solid structures were present (100 ×)
Fig. 3
Fig. 3
H&E staining of the surgical resection specimen. AB. The complicated growth pattern in the surgical specimen (20 ×). C-D. The tumor cells were arranged in a solid and cribriform pattern (40 ×). EF. Mucous cells and the intermediate cells with a reduced cytoplasm were observed (100 ×). GH. Myoepithelial cells melting with the stroma (200 ×)
Fig. 4
Fig. 4
IHC staining. AB. CK5/6 and P63 staining revealed the myoepithelial component in the tumor (100 × , 40 ×). C. CK7 staining revealed the ductal component in the tumor (40 ×). D. Negative S100 staining (100 ×). E. Low Ki-67 staining (approximately 10% positive) (100 ×). F. Positive AB staining in mucocytes (100 ×)
Fig. 5
Fig. 5
Intratumoral tumor-infiltrating lymphocytes expression of IHC. AB. The scarce positive for Intratumoral CD4 and CD8(100 ×). C. Negative CD80 staining(100 ×). D. Low level of intratumoral CD68-positive TILs (approximately 5%) (100 ×). E. Low level of intratumoral CD68-positive TILs (approximately 5%) (200 ×) F. Negative PD-L1 staining(100 ×)
Fig. 6
Fig. 6
RNA sequencing of EWSR1::BEND2 and GNAQ(intergenic)-EWSR1 fusions. A. RNA-based NGS revealed that EWSR1 was fused with BEND2 as the 3’ partner, an in-frame fusion of EWSR1 exon 8 with BEND2 exon 2 (Transcript accession: NM_013986.3/NM_153346.4. Breakpoint: chr22:29,683,123, chrX:18,234,853). B. RNA-based NGS revealed that a reading frame unclear fusion of GNAQ intergenic with EWSR1 exon 10 (Transcript accession: NM_002072.3/NM_013986.3. Breakpoint: chr9:80,333,072, chr22:29,686,054). C. FISH showed EWSR1 fused signal (yellow), and split signal (red and green). D. MAML2 FISH testing was negative

References

    1. Board WCoTE. Head and Neck Tumours WHO Classification of Tumours, 5th Edition, Volume 9. LYON, France: International Agency for Research on Cancer; 2024.
    1. Skálová A, Hyrcza MD, Leivo I (2022) Update from the 5th edition of the World Health Organization classification of head and neck tumors: salivary glands. Head Neck Pathol 16(1):40–53 - PMC - PubMed
    1. Skálová A, Bradová M, Michal M Jr et al (2024) Molecular pathology in diagnosis and prognostication of head and neck tumors. Virchows Archiv: Int J Pathol 484(2):215–231 - PMC - PubMed
    1. Todorovic E, Dickson BC, Weinreb I (2020) Salivary gland cancer in the era of routine next-generation sequencing. Head Neck Pathol 14(2):311–320 - PMC - PubMed
    1. Li Y, Xi SY, Yong JJ, Wu XY, Yang XH, Wang F (2021) Morphologic, immunohistochemical, and genetic differences between high-grade and low-grade fetal adenocarcinomas of the lung. Am J Surg Pathol 45(11):1464–1475 - PMC - PubMed

MeSH terms